Mosapride citrate
Sponsors
American University of Beirut Medical Center, Guang'anmen Hospital of China Academy of Chinese Medical Sciences, IlDong Pharmaceutical Co Ltd, Seoul National University Hospital, Kaichun Wu
Conditions
Colorectal PolypsConstipationConstipation-Predominant Irritable Bowel SyndromeDepressionDiabetes Mellitus, Type 2Diabetic GastroenteropathyFunctional DyspepsiaHealthy
Phase 1
A Drug Interaction Study of Mosapride and Rebamipide
CompletedNCT02106130
Start: 2013-05-31End: 2013-08-31Updated: 2014-04-08
Efficacy Assessment of Chinese Herbal Medicine Tangweian Recipe Treating Participants With Diabetic Gastroenteropathy
NCT05720442
Start: 2023-02-01End: 2026-01-01Target: 60Updated: 2023-02-09
Phase 3
Randomized Trial of Mosapride Versus Placebo in the Treatment of Constipation-Predominant Irritable Bowel Syndrome
TerminatedNCT00742872
Start: 2008-09-30End: 2010-06-30Updated: 2013-04-09
Efficacy and Safety of Acupuncture for Functional Constipation
CompletedNCT01411501
Start: 2011-09-30End: 2014-12-31Updated: 2015-12-11
Clinical Trial to Assess the Efficacy and Safety of Combination Therapy of Motireb 5/100 mg in Functional Dyspepsia Patients.
NCT02831543
Start: 2016-04-30End: 2017-06-30Target: 354Updated: 2016-07-13
Phase 4
The Effect of Combination of Mosapride and DPP-4 Inhibitor on Plasma Concentration of Incretin Hormones
CompletedNCT02180334
Start: 2014-07-31End: 2015-04-30Updated: 2017-11-29
Free-residue Nutrients for the Bowel Preparation of Colon Capsule Endoscopy
NCT02887573
Start: 2014-01-31End: 2017-07-31Target: 62Updated: 2017-02-07
Unknown Phase
Effect of Mosapride Citrate on Gastrointestinal Motility After Laparoscopic Gastrectomy
CompletedNCT04493125
Start: 2020-07-27End: 2021-03-30Updated: 2025-01-08
Zuojin Wan Combined With Rabeprazole or Mosapride for the Treatment of Functional Dyspepsia Combined With Depression
Not yet recruitingNCT06481371
Start: 2024-06-30End: 2025-04-30Target: 120Updated: 2024-07-01